Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ICOS is widely expressed in cutaneous T-cell lymphoma, and its targeting promotes potent killing of malignant cells
F. Amatore, Nicolás Ortonne, Marc Lopez, et al.
Blood Advances (2020) Vol. 4, Iss. 20, pp. 5203-5214
Open Access | Times Cited: 21

Showing 21 citing articles:

Targeting the Inducible T-cell Costimulator (ICOS) in Patients with Relapsed/Refractory T-follicular Helper Phenotype Peripheral T-cell and Angioimmunoblastic T-cell Lymphoma
Julio C. Chávez, Francine M. Foss, Basem M. William, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 10, pp. 1869-1878
Closed Access | Times Cited: 16
Mycosis Fungoides and Sézary Syndrome: Microenvironment and Cancer Progression
Gábor Dobos, Ingrid Lazaridou, Adèle de Masson
Cancers (2023) Vol. 15, Iss. 3, pp. 746-746
Open Access | Times Cited: 10
Triscysteine disulfide-directing motifs enabling design and discovery of multicyclic peptide binders
Zengping Duan, Chuilian Kong, Shihui Fan, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Expression of immune checkpoint molecules programmed death protein 1, programmed death‐ligand 1 and inducible T‐cell co‐stimulator in mycosis fungoides and Sézary syndrome: association with disease stage and clinical outcome*
Cosimo Di Raimondo, Belén Rubio-González, Joycelynne Palmer, et al.
British Journal of Dermatology (2022) Vol. 187, Iss. 2, pp. 234-243
Open Access | Times Cited: 15
Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives
Gabriele Roccuzzo, Silvia Giordano, Paolo Fava, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 20
Advances in Immunotherapy for the Treatment of Cutaneous T-Cell Lymphoma
Ari Pelcovits, Thomas Ollila, Adam J. Olszewski
Cancer Management and Research (2023) Vol. Volume 15, pp. 989-998
Open Access | Times Cited: 7
Identification of a Gene Prognostic Signature for Oral Squamous Cell Carcinoma by RNA Sequencing and Bioinformatics
Yangyang Zhang, Minghui Mao, Zhengxue Han
BioMed Research International (2021) Vol. 2021, pp. 1-14
Open Access | Times Cited: 15
Updates in the Treatment of Peripheral T-Cell Lymphomas
Khalil Saleh, Jean‐Marie Michot, Vincent Ribrag
Journal of Experimental Pharmacology (2021) Vol. Volume 13, pp. 577-591
Open Access | Times Cited: 11
CD158k and PD-1 expressions define heterogeneous subtypes of Sezary syndrome
Inès Vergnolle, Claudia Douat-Beyries, S. Boulinguez, et al.
Blood Advances (2021) Vol. 6, Iss. 6, pp. 1813-1825
Open Access | Times Cited: 10
How molecular advances may improve the diagnosis and management of PTCL patients
Fanny Drieux, François Lemonnier, Philippe Gaulard
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3
Cutaneous Lymphoma and Antibody-Directed Therapies
Alvise Sernicola, Christian Ciolfi, Paola Miceli, et al.
Antibodies (2023) Vol. 12, Iss. 1, pp. 21-21
Open Access | Times Cited: 2
Education and Empowering Special Forces to Eradicate Secret Defectors: Immune System-Based Treatment Approaches for Mature T- and NK-Cell Malignancies
Till Braun, Alexandra Schrader
Cancers (2023) Vol. 15, Iss. 9, pp. 2532-2532
Open Access | Times Cited: 2
Challenging Cutaneous T-Cell Lymphoma: What Animal Models Tell us So Far
Antonella Bresin, Elisabetta Caprini, Giandomenico Russo, et al.
Journal of Investigative Dermatology (2022) Vol. 142, Iss. 6, pp. 1533-1540
Open Access | Times Cited: 4
INA03: A Potent Transferrin-Competitive Antibody–Drug Conjugate against CD71 for Safer Acute Leukemia Treatment
Manuela Bratti, Elisa Stubbs, Sergii Kolodych, et al.
Molecular Cancer Therapeutics (2024) Vol. 23, Iss. 8, pp. 1159-1175
Closed Access
Stage‐related increase in PIM2 expression in mycosis fungoides
Mie Holm Nielsen, Pia Rude Nielsen, Michael Bzorek, et al.
Apmis (2024) Vol. 132, Iss. 8, pp. 564-570
Closed Access
The Value of Immunohistochemical Expression of TOX, ICOS, and GATA-3 in the Diagnosis of Mycosis Fungoides
Hanaa Atwa, Doaa I. Abdelrahman
Applied immunohistochemistry & molecular morphology (2023)
Closed Access | Times Cited: 1
Skin involvement in systemic lymphoma of follicular helper T‐cell origin: A cohort study of 57 patients
Romain Stammler, Maxime Battistella, Julien Calvani, et al.
JEADV Clinical Practice (2023) Vol. 2, Iss. 4, pp. 727-738
Open Access | Times Cited: 1
Mass Cytometric Analysis of Early-Stage Mycosis Fungoides
Nannan Guo, Jia Li, Coby Out‐Luiting, et al.
Cells (2022) Vol. 11, Iss. 7, pp. 1062-1062
Open Access | Times Cited: 2
Innate and adaptive immunity in cancer
Aatman S. Doshi, Kirtika H. Asrani
Elsevier eBooks (2021), pp. 19-61
Closed Access | Times Cited: 2
Immune Checkpoint Molecules and Co-stimulatory Molecules in Cutaneous T-cell Lymphoma
Tomomitsu Miyagaki
The Nishinihon Journal of Dermatology (2022) Vol. 84, Iss. 3, pp. 187-193
Closed Access
Physiopathologie des lymphomes T cutanés épidermotropes (Mycosis fongoïde et syndrome de Sézary)
F. Amatore, Maxime Battistella, Nicolás Ortonne
Annales de Dermatologie et de Vénéréologie - FMC (2022) Vol. 3, Iss. 2, pp. 120-124
Open Access
Page 1

Scroll to top